This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • External Eye Disease  • Ocular/ Adnexal Tumors  • Alert me on articles by topic

Ingrid Boldin, MD; Gudrun Brix-Grünwald, MD; Michael M. Scarpatetti, MD; Christine Beham-Schmid, MD, PhD; Angelika Klein, MD

Arch Ophthalmol. 2008;126(5):738-740.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Interdigitating dendritic cells participate in the immune system as antigen-presenting cells, stimulating T lymphocytes. Interdigitating dendritic cells normally are localized in the T-cell–rich areas of lymph nodes and are believed to be derived from hematopoietic precursors and to belong to the mononuclear phagocytic system. Interdigitating dendritic cells sarcoma is an extremely rare malignancy derived from these antigen-presenting cells normally localized in lymphoid organs. Only 45 cases have been reported in the literature to date.^1-2 We are unaware of previous reports of this sarcoma in the eyelid and could not find any reference to it in a MEDLINE search.

Report of a Case

A 72-year-old man who had an unknown recurrent lesion in his lower right eyelid for 8 months was referred to our department. Two prior biopsies revealed a nevoid lesion and dermatofibroma. The patient was referred . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION